Use of discriminant analysis based on echocardiography for classification of congestive heart failure in dogs with myxomatous mitral valve disease

被引:0
|
作者
Silva, A. C. [1 ]
Muzzi, R. A. L. [1 ]
Muzzi, L. A. L. [1 ]
Ferreira, D. F. [1 ]
Oberlender, G. [1 ]
Oliveira, M. S. [1 ]
Nogueira, R. B. [1 ]
Ticle, L. B. [2 ]
机构
[1] Univ Fed Lavras, UFLA, Lavras, MG, Brazil
[2] Hosp Vaz Monteiro, Lavras, MG, Brazil
关键词
canine; cardiac disease; statistical model; vena contracta; VENA CONTRACTA AREA; DOPPLER-ECHOCARDIOGRAPHY; NATURAL-HISTORY; REGURGITATION; SEVERITY; PREDICTION; MORTALITY;
D O I
10.1590/1678-6800
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Mixomatous mitral valve disease (MMVD) is one of the most common cardiac abnormalities in dogs and humans that can lead to cardiac heart failure (CHF). Its diagnosis remains based on echocardiography and clinical signs. However, the early diagnose of MMVD can contribute to a better prognosis and avoid CHF. The aim of this study was to evaluate the clinical, radiographic and echocardiographic presence of CHF in dogs with MMVD in combination with a statistical model as a mathematical tool. For this purpose, dogs were divided into three groups (healthy; MMVD without CHF; and MMVD with CHF), according the clinical, radiographic and echocardiographic evaluation findings. Thus, linear discriminant functions were obtained by analyzing the variables weight, body surface area, aortic diameter, the ratio of the left atrium/aortic diameter, the ratio between the mitral regurgitation jet area and the left atrial area, vena contracta diameter and mitral valve proximal isovelocity surface area. Then, mathematical equations were established for each group of dogs. Statistical functions obtained in this study enabled to classify the dogs, regarding the presence of CHF with a probability of correct classification of 90.4%. Thus the statistical model demonstrated that it could be used as an auxiliary method for identifying CHF in dogs with MMVD.
引用
下载
收藏
页码:1727 / 1734
页数:8
相关论文
共 50 条
  • [31] Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
    Valente, Carlotta
    Guglielmini, Carlo
    Toaldo, Marco Baron
    Romito, Giovanni
    Artusi, Carlo
    Brugnolo, Laura
    Contiero, Barbara
    Poser, Helen
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [32] Improving outcomes of myxomatous mitral valve disease in dogs
    Boswood, Adrian
    IN PRACTICE, 2018, 40 : 12 - 15
  • [33] Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease:: The QUEST study
    Haggstrom, J.
    Boswood, A.
    O'Grady, M.
    Joens, O.
    Smith, S.
    Swift, S.
    Borgarelli, M.
    Gavaghan, B.
    Kresken, J. -G.
    Patteson, M.
    Ablad, B.
    Bussadori, C. M.
    Glaus, T.
    Kovacevic, A.
    Rapp, M.
    Santilli, R. A.
    Tidholm, A.
    Eriksson, A.
    Belanger, M. C.
    Deinert, M.
    Little, C. J. L.
    Kvart, C.
    French, A.
    Ronn-Landbo, M.
    Wess, G.
    Eggertsdottir, A. V.
    O'Sullivan, M. L.
    Schneider, M.
    Lombard, C. W.
    Dukes-McEwan, J.
    Willis, R.
    Louvet, A.
    DiFruscia, R.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (05) : 1124 - 1135
  • [34] Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease
    Yata, Mariko
    Kooistra, Hans S.
    Beijerink, Niek J.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2019, 33 (02) : 462 - 470
  • [35] Effect of Pimobendan or Benazepril Hydrochloride on survival times in dogs with congestive heart failure caused by naturally occuring myxomatous mitral valve disease: the QUEST study
    Haggstrom, J.
    Boswood, A.
    O'Grady, M.
    Jons, O.
    Smith, S.
    Swift, S.
    Borgarelli, M.
    Gavaghan, B.
    Kresken, J.-G.
    Patteson, M.
    Ablad, B.
    Bussadori, C. M.
    Giaus, T.
    Kovacevic, A.
    Rapp, M.
    Santilli, R. A.
    Tidholm, A.
    Eriksson, A.
    Belanger, M. C.
    Deinert, M.
    Little, C. J. L.
    Kvart, C.
    French, A.
    Ronn-Landbo, M.
    Wess, G.
    Eggertsdottir, A., V
    O'Sullivan, M. L.
    Schneider, M.
    Lombard, C. W.
    Dukes-McEwan, J.
    Willis, R.
    Louvet, A.
    DiFruscia, R.
    KLEINTIERPRAXIS, 2008, 53 (12): : 745 - +
  • [36] Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease
    Hezzell, Melanie J.
    Block, Chloe L.
    Laughlin, Danielle S.
    Oyama, Mark A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2018, 32 (05): : 1509 - 1516
  • [37] MYXOMATOUS MITRAL VALVE DISEASE IN DOGS - AN UPDATE AND PERSPECTIVES
    Petric, Aleksandra Domanjko
    MACEDONIAN VETERINARY REVIEW, 2015, 38 (01) : 13 - 20
  • [38] THROMBOELASTOGRAPHY IN DOGS WITH ASYMPTOMATIC MYXOMATOUS MITRAL VALVE DISEASE
    Tarnow, I.
    Olsen, L. H.
    Moesgaard, S. G.
    Martinsen, A. U.
    Birkegaard, A. C.
    Kristensen, A. T.
    Wiinberg, B.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2010, 24 (03) : 673 - 673
  • [39] Iron status in dogs with myxomatous mitral valve disease
    Savarese, A.
    Probo, M.
    Locatelli, C.
    Gazzonis, A. L.
    Zanzani, S. A.
    Traini, G.
    Vitiello, T.
    Brambilla, P. G.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2018, 21 (03): : 507 - 515
  • [40] DOPPLER-DERIVED MAXIMUM DP/DT IN DIAGNOSIS OF CONGESTIVE HEART FAILURE IN CANINE MYXOMATOUS MITRAL VALVE DISEASE
    Kim, Jun-hwan
    Kim, Jung-hyun
    Lee, Hyunseok
    Kim, Yun-hye
    Baek, Dae-seong
    Park, Hee-Myung
    Park, Jinho
    Park, Chul
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2013, 27 (03) : 647 - 647